Last reviewed · How we verify
Chronic phase chronic myeloid leukemia
Approved treatments
- Gleevec · M.D. Anderson Cancer Center
- Sprycel · Handa Therap
Sprycel works by blocking the activity of a specific protein called Ephrin type-B receptor 6, which is involved in the growth and survival of cancer cells. - Gleevec · Novartis
Gleevec works by blocking the activity of specific enzymes involved in cancer cell growth and proliferation. - Tasigna · Cipla
Tasigna works by blocking the abnormal Bcr/Abl protein that drives the growth of cancer cells in CML. - Tasigna · XSpray Microparticles
Clinical guidelines
- FDA label — 1L
Dasatinib is indicated for the treatment of newly diagnosed adult patients with Ph+ CML in chronic phase. - FDA label — 1L
Dasatinib is indicated for the treatment of pediatric patients 1 year of age and older with Ph+ CML in chronic phase. - FDA label — 1L
Dasatinib is indicated for the treatment of pediatric patients 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic phase chronic myeloid leukemia patent landscape — cliff calendar, originator estates, attackable patents
- Chronic phase chronic myeloid leukemia treatment landscape brief
- Chronic phase chronic myeloid leukemia treatment updates RSS
Frequently asked questions about Chronic phase chronic myeloid leukemia
What drugs treat Chronic phase chronic myeloid leukemia?
Tracked treatments include Gleevec, Sprycel, Tasigna.
What is the treatment for Chronic phase chronic myeloid leukemia?
Standard treatment for Chronic phase chronic myeloid leukemia includes Gleevec, Sprycel, Tasigna. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Chronic phase chronic myeloid leukemia?
FDA label publishes guidelines for Chronic phase chronic myeloid leukemia. 3 guideline references tracked.
Related
- Treatment landscape: Chronic phase chronic myeloid leukemia patent cliff · Chronic phase chronic myeloid leukemia CI report
- Treatment: Gleevec · M.D. Anderson Cancer Center
- Treatment: Sprycel · Handa Therap
- Treatment: Gleevec · Novartis
- Treatment: Tasigna · Cipla
- Treatment: Tasigna · XSpray Microparticles
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing